Publication date context February 11 2026. A new trial proposal from Rigshospitalet Denmark along with Aarhus University Hospital and Aalborg University Hospital seeks to study the use of a telepresence robot with school navigation to support children undergoing cancer treatment. The plan focuses on reducing fragmentation in education and care that can occur when treatment disrupts regular school attendance and social participation. The project is described as not yet recruiting and is listed on ClinicalTrials.gov under NCT07398677.
Interventions include a device described as a telepresence robot, as well as a school navigator and teleteaching with technical support. The combination is intended to enable remote classroom presence, coordinated educational planning, and ongoing technical assistance while a child undergoes treatment.
This news item is written in a medical device regulation style with attention to intended purpose, performance and safety as described by the sponsors. The information comes from the ClinicalTrials.gov record and sponsor disclosures. The sponsors and sites emphasize a patient centered approach that preserves school attendance and social well being for childhood cancer survivors.
What changed for education and care in pediatric cancer treatment?
The introduction of a telepresence option combined with a school navigator represents a shift toward preserving education during cancer treatment. The collaboration among Rigshospitalet and partner hospitals signals a coordinated effort to align hospital care with school routines. Stakeholders including families and educators may benefit from improved continuity in attendance and academic planning, particularly for children who experience prolonged hospital stays or frequent absences.
The project explicitly identifies the components of the intervention as a telepresence device, a school navigator, and teleteaching with technical support. This configuration aims to enable participation in classes while at a hospital or in home settings, and to support social connection with peers. The model aligns with a broader interest in patient centered care that integrates education and clinical needs.
What is the device and what supports are included?
The trial lists three main interventions. First a device described as a telepresence robot is included. Second a school navigator is employed to help families manage attendance schedules transitions between schools and educational planning. Third teleteaching and technical support provide access to class content and reliable connectivity to learning platforms. Together these elements are intended to reduce barriers to learning and social interaction during cancer treatment.
- Telepresence robot enables real time classroom participation from hospital or home settings
- School navigator coordinates scheduling school transitions and educational planning
- Teleteaching and technical support ensures access to learning materials and reliable connectivity
What are the regulatory implications and next steps?
The listing shows the project as not yet recruiting, indicating that future regulatory evaluation will consider safety performance and intended use. While the article presents a regulatory style framing, the specific device class and conformity assessment requirements will depend on how the sponsors define the device as a medical device in the governing jurisdiction. The sponsors are required to demonstrate safety and effectiveness for the described use and to maintain appropriate risk management records as the project advances. Readers should monitor the ClinicalTrials.gov listing for updates and for any changes in recruitment status or study design.
FAQ
- What is the purpose of the trial and what problem does it address? The trial aims to assess whether a telepresence robot combined with school navigation and teaching support can help maintain education and social integration for children undergoing cancer treatment.
- Who is conducting the trial and where is it based? The trial is led by Rigshospitalet and two other Danish hospitals, with Aarhus University Hospital and Aalborg University Hospital involved.
- What components are included in the intervention? The intervention consists of a telepresence robot, a school navigator, and teleteaching with technical support.
- What is the recruitment status? The trial is listed as not yet recruiting on ClinicalTrials.gov.
- Where can official information be found? The ClinicalTrials.gov listing provides the official description and status for NCT07398677.
Conclusion
If the trial proceeds and safety and performance are demonstrated, this approach may support education continuity for children facing cancer treatment. Regulators and health systems will look for clear indications of user safety, data handling and durable connectivity. Clinicians and school partners should consider how such a model could integrate with existing care pathways while preserving patient rights and privacy. The next steps include recruitment updates, protocol refinement and ongoing risk management assessments as the study progresses.
Disclaimer
This article is intended for professional use only and provides informational analysis based on the source material. It is not legal advice or an offer to market a medical device. For formal guidance contact the relevant regulatory authorities.
Announcement line
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07398677?term=medical+device